PubRank

K Czerwenka

Author PubWeight™ 64.18‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. Oncogene 1989 1.41
2 Adjuvant tamoxifen in postmenopausal stage II breast cancer five years on. Lancet 1990 1.41
3 [Tumoral vascular density in breast tumors and their effect on recurrence-free survival]. Chirurg 1994 1.40
4 MMP-1 and MMP-2 expression in uterine leiomyosarcoma and correlation with different clinicopathologic parameters. J Soc Gynecol Investig 2003 1.40
5 [Adjuvant hormonal therapy in lymph node-negative breast carcinoma patients in the postmenopause]. Dtsch Med Wochenschr 1992 1.39
6 Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol 1999 1.34
7 Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol 2001 1.33
8 Patterns of DNA amplification at band q13 of chromosome 11 in human breast cancer. Genes Chromosomes Cancer 1994 1.27
9 EGFR and steroid receptors in ovarian carcinoma: comparison with prognostic parameters and outcome of patients. Anticancer Res 1997 1.26
10 Vascular endothelial growth factor (VEGF) in human breast cancer: correlation with disease-free survival. Int J Cancer 1997 1.16
11 Association of in vitro invasiveness and gene expression of estrogen receptor, progesterone receptor, pS2 and plasminogen activator inhibitor-1 in human breast cancer cell lines. Breast Cancer Res Treat 1999 1.15
12 Co-expression of ErbB-family members in human breast cancer: Her-2/neu is the preferred dimerization candidate in nodal-positive tumors. Breast Cancer Res Treat 2003 1.12
13 Presence of nanobacteria in psammoma bodies of ovarian cancer: evidence for pathogenetic role in intratumoral biomineralization. Histopathology 2004 1.07
14 Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J Immunol 1995 1.05
15 Human cervical ripening is associated with an increase in cervical inducible nitric oxide synthase expression. Biol Reprod 1999 0.99
16 Human papillomavirus in the cervix and placenta. Obstet Gynecol 2000 0.99
17 Primary malignant melanoma of the vagina: long-term remission following radiation therapy. Gynecol Oncol 1998 0.95
18 Progesterone increases the number of Langerhans cells in human vaginal epithelium. Fertil Steril 2001 0.94
19 Fluorescence in situ hybridization in cervical smears: detection of numerical aberrations of chromosomes 7, 3, and X and relationship to HPV infection. Gynecol Oncol 1999 0.93
20 First experience with FGF-3 (INT-2) amplification in women with epithelial ovarian cancer. Br J Cancer 1993 0.93
21 Long-term influence of adjuvant therapy on natural killer cell activity in breast cancer. Cancer Immunol Immunother 1988 0.90
22 Radioimmunodetection in patients with suspected ovarian cancer. J Nucl Med 1985 0.90
23 Differential expression of cell surface integrins on human mast cells and human basophils. Ann Hematol 1992 0.89
24 Human papillomavirus DNA integration and messenger RNA transcription in cervical low- and high-risk squamous intraepithelial lesions in Austrian women. Int J Gynecol Cancer 2007 0.89
25 Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis. Reprod Sci 2007 0.89
26 Her-2/neu-triggered intracellular tyrosine kinase activation: in vivo relevance of ligand-independent activation mechanisms and impact upon the efficacy of trastuzumab-based treatment. Br J Cancer 2003 0.89
27 Intratumoral IGF-I protein expression is selectively upregulated in breast cancer patients with BRCA1/2 mutations. Endocr Relat Cancer 2007 0.89
28 HER-2 and INT-2 amplification estimated by quantitative PCR in paraffin-embedded ovarian cancer tissue samples. Eur J Cancer 1993 0.88
29 Microvessel density and vessel invasion in lymph-node-negative breast cancer: effect on recurrence-free survival. Int J Cancer 1995 0.88
30 Axillary lymph nodes in breast cancer: is size related to metastatic involvement? World J Surg 2000 0.87
31 Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patients. Cancer Lett 1998 0.87
32 Interleukin 1alpha and tissue-lytic matrix metalloproteinase-1 are elevated in ectopic endometrium of patients with endometriosis. Hum Reprod 2005 0.87
33 Expression of inducible nitric oxide synthase in human breast cancer depends on tumor grade. Breast Cancer Res Treat 1999 0.87
34 Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer. Clin Cancer Res 1999 0.85
35 Differential response of human basophils and mast cells to recombinant chemokines. Ann Hematol 1995 0.84
36 Interleukin-1alpha protein secretion in breast cancer is associated with poor differentiation and estrogen receptor alpha negativity. Int J Gynecol Cancer 2006 0.84
37 Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone? Eur J Obstet Gynecol Reprod Biol 2001 0.84
38 Presence of endothelial calcium-dependent nitric oxide synthase in breast apocrine metaplasia. Br J Cancer 1996 0.83
39 The influence of cotinine on interleukin 6 expression in smokers with cervical preneoplasia. Acta Obstet Gynecol Scand 2000 0.83
40 Decreased expression of ICAM-1 and its induction by tumor necrosis factor on breast-cancer cells in vitro. Int J Cancer 1997 0.83
41 Evidence of hepatitis C virus in cervical smears. J Infect 1999 0.82
42 Specific activation of human mast cells by the ligand for c-kit: comparison between lung, uterus and heart mast cells. Int Arch Allergy Immunol 1993 0.82
43 Diagnostic value of mucin-like carcinoma-associated antigen (MCA) in breast cancer. Eur J Cancer Clin Oncol 1989 0.82
44 Expression of homing receptors and related molecules on human mast cells and basophils: a comparative analysis using multi-color flow cytometry and toluidine blue/immunofluorescence staining techniques. Tissue Antigens 1999 0.81
45 Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. J Soc Gynecol Investig 2004 0.81
46 Effects of cyclosporin A and FK-506 on stem cell factor-induced histamine secretion and growth of human mast cells. J Allergy Clin Immunol 1996 0.81
47 EGF-R and steroid receptors in breast cancer: a comparison with tumor grading, tumor size, lymph node involvement, and age. Clin Biochem 1993 0.81
48 Increased natural killer cell activity correlates with low or negative expression of the HER-2/neu oncogene in patients with breast cancer. Cancer 1994 0.81
49 Expression of aromatase and estrogen sulfotransferase in preinvasive and invasive breast cancer. J Cancer Res Clin Oncol 2007 0.81
50 Proteomics in mammary cancer research. Eur J Gynaecol Oncol 2009 0.80
51 DNA amplification of HER-2/neu and INT-2 oncogenes in epithelial ovarian cancer. Gynecol Oncol 1995 0.80
52 Malignant mixed Müllerian tumor with heterologous component arising in the fallopian tube--a case report. Eur J Gynaecol Oncol 2006 0.80
53 Expression of the vitamin D receptor, of estrogen and thyroid hormone receptor alpha- and beta-isoforms, and of the androgen receptor in cultures of native mouse bone marrow and of stromal/osteoblastic cells. Bone 1999 0.79
54 Papilloma virus and c-erbB-2 expression in diseases of the mammary nipple. Anticancer Res 2001 0.78
55 [The role of nitric oxide in reproduction]. Gynakol Geburtshilfliche Rundsch 1998 0.78
56 Induction of inducible nitric oxide synthase expression in human secretory endometrium. Hum Reprod 1998 0.78
57 Combined use of 123I-labelled BCD-F9 and 4C4 monoclonal antibody with dissimilar specificity for breast cancer: implication for the detection limit of immunolymphoscintigraphy in the assessment of axillary lymph node metastases. Nucl Med Commun 1994 0.78
58 Prognostic significance of cell DNA content in early-stage ovarian cancer (FIGO stages I and II/A) by means of automatic image cytometry. Int J Cancer 1994 0.78
59 The detection of HPV DNA improves the recognition of cervical intraepithelial lesions. Arch Gynecol Obstet 2002 0.78
60 Association of increased lytic effector cell function with high estrogen receptor levels in tumor-bearing patients with breast cancer. Cancer 1989 0.78
61 [Therapeutic and prognostic results of a prospective multicenter ovarian cancer study of FIGO stages I and II]. Geburtshilfe Frauenheilkd 1987 0.77
62 Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patients. Acta Oncol 2000 0.77
63 The relation between depth of trophoblastic invasion and beta-HCG levels in tubal pregnancies. Arch Gynecol Obstet 1995 0.77
64 Oncogenic potential of c-erbB-2 and its association with c-K-ras in premalignant and malignant lesions of the human uterine endometrium. Tumour Biol 2001 0.77
65 Elevation of inducible nitric oxide synthase activity in human endometrium during menstruation. Biol Reprod 1999 0.77
66 [Tumor vascular invasion in breast carcinoma. Hematoxylin-eosin versus immunohistochemical staining for factor VIII antigen]. Dtsch Med Wochenschr 1994 0.77
67 [Adjuvant hormone therapy in endometrial carcinoma: medroxyprogesterone acetate versus tamoxifen-medroxyprogesterone acetate sequential therapy]. Gynakol Rundsch 1990 0.76
68 HER-2 amplification but not butyrylcholinesterase multability reflects aggressiveness of European-originated ovarian tumors. Gynecol Oncol 1995 0.76
69 Hybrid capture based human papillomavirus typing in cervical screening compared to cytology and histology. Wien Klin Wochenschr 2000 0.76
70 Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study. Anticancer Res 2001 0.75
71 Response of the endosalpinx to potential irritants. Fertil Steril 1994 0.75
72 Detection of oestrogen and progesterone receptor expression in breast tumors by semiquantitative PCR. Anticancer Res 1998 0.75
73 [Amplification and expression of c-erbB2 oncogene in normal, hyperplastic, and malignant endometria]. Zhonghua Fu Chan Ke Za Zhi 1996 0.75
74 [Immune lymphoscintigraphy in gynecologic oncology]. Gynakol Rundsch 1991 0.75
75 [Histopathologic findings of the trophoblast and tubal wall after medicamentous therapy of tubal pregnancies]. Geburtshilfe Frauenheilkd 1995 0.75
76 [Axillary metastases of unknown primary carcinoma]. Geburtshilfe Frauenheilkd 1996 0.75
77 Basaloid carcinoma and keratinizing squamous cell carcinoma of the vulva: a case of two primary carcinomas. Anticancer Res 1996 0.75
78 [A small cancer of the breast--occult breast cancer]. Rontgenpraxis 1987 0.75
79 Amplification and expression of the c-erbB-2 oncogene in Müllerian-derived genital-tract tumors. Gynecol Oncol 1998 0.75
80 The danger of neovascularization in invasive gestational trophoblastic disease. Acta Obstet Gynecol Scand 1998 0.75
81 Impact of trophoblast penetration through the basal membrane on the efficacy of drug therapy in tubal pregnancies. Hum Reprod 1995 0.75
82 Interleukin-1 system and sex steroid receptor gene expression in human endometrial cancer. Gynecol Oncol 2002 0.75
83 [Is consecutive curettage of the corpus uteri indicated in every conization case?]. Geburtshilfe Frauenheilkd 1990 0.75
84 Proliferative cell activity in correlation to human chorionic gonadotrophin release of trophoblast tissue of tubal pregnancy. Hum Reprod 1997 0.75
85 [The vaginal smear and hormonal status]. Gynakol Rundsch 1986 0.75
86 [Ultrasound-guided cyst puncture of the human breast]. Wien Med Wochenschr 1987 0.75
87 [Extensive intraductal components of invasive ductal breast carcinoma--value of mammography]. Rofo 1994 0.75
88 The accuracy of transrectal aspiration biopsy of the prostate: an analysis of 452 cases. Prostate 1984 0.75
89 [The effect of p-bromophenacylbromide, a phospholipase A inhibitor, in experimental acute pancreatitis in rats]. Res Exp Med (Berl) 1984 0.75
90 [Epidermal growth factor receptor in human breast cancer: correlation with steroid receptors, tumor stage, grading and menopausal status]. Geburtshilfe Frauenheilkd 1992 0.75
91 [Thanatophoric dwarfism. Pathogenesis of the respiratory insufficiency in this abnormality]. Zentralbl Gynakol 1976 0.75
92 Fibrosarcoma of the uterus: a case report. Anticancer Res 2002 0.75
93 [Effect of various factors on survival after recurrent and/or metastatic breast cancer]. Geburtshilfe Frauenheilkd 1991 0.75
94 [Breast ductal carcinoma in situ. The clinical image in the mammogram]. Rofo 1994 0.75
95 [Diagnostic and therapeutic consequences of round lesions of the benign type in the breast]. Gynakol Rundsch 1987 0.75
96 Parity as an independent prognostic factor in malignant mixed mesodermal tumors of the endometrium. Gynecol Oncol 1997 0.75
97 [Metastatic spread of extramammary malignant melanomas to the female breast and the clinical consequences]. Zentralbl Gynakol 1988 0.75
98 Detection of human papillomavirus on Papanicolaou-stained cervical smears using indirect in situ polymerase chain reaction hybridization. Arch Pathol Lab Med 2001 0.75
99 [Vaginal pathogens and cervix lesions]. Gynakol Rundsch 1989 0.75
100 Estrogen does not induce the calcium-dependent nitric oxide synthase in cultured human uterine endothelial and myometrial smooth muscle cells. J Vasc Res 1997 0.75
101 Predicting the clinical course of breast cancer patients undergoing trastuzumab-based therapy: an outlook. Methods Find Exp Clin Pharmacol 2004 0.75
102 [Immunolymphoscintigraphy. A new procedure for noninvasive lymph node staging illustrated by the example of breast cancer]. Dtsch Med Wochenschr 1988 0.75
103 [The value of the "vascular invasion" factor for prognosis of breast cancer]. Geburtshilfe Frauenheilkd 1994 0.75
104 [Immunohistochemical diagnosis in breast cancers]. Gynakol Rundsch 1988 0.75
105 [Importance of platinum dose intensity in treatment of epithelial ovarian cancer. Austrian Study Group for Therapy of Ovarian Cancer]. Wien Klin Wochenschr 1993 0.75
106 [The treatment of virus-associated cervix dysplasia with recombinant interferon alpha-2c or gamma]. Gynakol Rundsch 1989 0.75
107 C-erbB-2 amplification and expression in gestational trophoblastic disease correlates with DNA content and karyotype. Gen Diagn Pathol 1997 0.75
108 IL-1alpha gene expression in human endometrial cancer is independent of ovarian steroid receptor expression. Eur J Cancer 2002 0.75
109 [Melanoma of the vulva. Report of 12 cases]. Geburtshilfe Frauenheilkd 1991 0.75
110 Adjuvant tamoxifen in postmenopausal patients with breast cancer and negative axillary lymph nodes. Eur J Cancer 1992 0.75